TARGET National: A UK-wide Liquid-based Molecular Profiling Programme: On Behalf of the TARGET National Consortium.

Ortega-Franco, A; Darlington, E; Greystoke, A; Krebs, M G

Ortega-Franco, A; Darlington, E; Greystoke, A; Krebs, M G.

Afiliação

Ortega-Franco A; The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Darlington E; The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Greystoke A; Translational and Clinical Research Institute, NU Cancer, Newcastle University, Newcastle upon Tyne, UK; Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Krebs MG; The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Electronic address: matthew.krebs@manchester.ac.uk.

Clin Oncol (R Coll Radiol) ; 35(1): 33-37, 2023 01.

Article em En | MEDLINE | ID: mdl-36335040

Assuntos

Neoplasias Pulmonares; Humanos; Biomarcadores Tumorais; Reino Unido; Mutação

Palavras-chave

Early phase clinical trial; Genomic profiling; Liquid biopsy; Precision medicine; Targeted therapy; ctDNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Clin Oncol (R Coll Radiol) Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google